Cargando…

Architecture and hydration of the arginine‐binding site of neuropilin‐1

Neuropilin‐1 (NRP1) is a transmembrane co‐receptor involved in binding interactions with variety of ligands and receptors, including receptor tyrosine kinases. Expression of NRP1 in several cancers correlates with cancer stages and poor prognosis. Thus, NRP1 has been considered a therapeutic target...

Descripción completa

Detalles Bibliográficos
Autores principales: Mota, Filipa, Fotinou, Constantina, Rana, Rohini R., Chan, A. W. Edith, Yelland, Tamas, Arooz, Mohamed T., O'Leary, Andrew P., Hutton, Jennie, Frankel, Paul, Zachary, Ian, Selwood, David, Djordjevic, Snezana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947257/
https://www.ncbi.nlm.nih.gov/pubmed/29430837
http://dx.doi.org/10.1111/febs.14405
_version_ 1783322335144574976
author Mota, Filipa
Fotinou, Constantina
Rana, Rohini R.
Chan, A. W. Edith
Yelland, Tamas
Arooz, Mohamed T.
O'Leary, Andrew P.
Hutton, Jennie
Frankel, Paul
Zachary, Ian
Selwood, David
Djordjevic, Snezana
author_facet Mota, Filipa
Fotinou, Constantina
Rana, Rohini R.
Chan, A. W. Edith
Yelland, Tamas
Arooz, Mohamed T.
O'Leary, Andrew P.
Hutton, Jennie
Frankel, Paul
Zachary, Ian
Selwood, David
Djordjevic, Snezana
author_sort Mota, Filipa
collection PubMed
description Neuropilin‐1 (NRP1) is a transmembrane co‐receptor involved in binding interactions with variety of ligands and receptors, including receptor tyrosine kinases. Expression of NRP1 in several cancers correlates with cancer stages and poor prognosis. Thus, NRP1 has been considered a therapeutic target and is the focus of multiple drug discovery initiatives. Vascular endothelial growth factor (VEGF) binds to the b1 domain of NRP1 through interactions between the C‐terminal arginine of VEGF and residues in the NRP1‐binding site including Tyr297, Tyr353, Asp320, Ser346 and Thr349. We obtained several complexes of the synthetic ligands and the NRP1‐b1 domain and used X‐ray crystallography and computational methods to analyse atomic details and hydration profile of this binding site. We observed side chain flexibility for Tyr297 and Asp320 in the six new high‐resolution crystal structures of arginine analogues bound to NRP1. In addition, we identified conserved water molecules in binding site regions which can be targeted for drug design. The computational prediction of the VEGF ligand‐binding site hydration map of NRP1 was in agreement with the experimentally derived, conserved hydration structure. Displacement of certain conserved water molecules by a ligand's functional groups may contribute to binding affinity, whilst other water molecules perform as protein–ligand bridges. Our report provides a comprehensive description of the binding site for the peptidic ligands’ C‐terminal arginines in the b1 domain of NRP1, highlights the importance of conserved structural waters in drug design and validates the utility of the computational hydration map prediction method in the context of neuropilin. DATABASE: The structures were deposited to the PDB with accession numbers PDB ID: 5IJR, 5IYY, 5JHK, 5J1X, 5JGQ, 5JGI.
format Online
Article
Text
id pubmed-5947257
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-59472572018-05-17 Architecture and hydration of the arginine‐binding site of neuropilin‐1 Mota, Filipa Fotinou, Constantina Rana, Rohini R. Chan, A. W. Edith Yelland, Tamas Arooz, Mohamed T. O'Leary, Andrew P. Hutton, Jennie Frankel, Paul Zachary, Ian Selwood, David Djordjevic, Snezana FEBS J Original Articles Neuropilin‐1 (NRP1) is a transmembrane co‐receptor involved in binding interactions with variety of ligands and receptors, including receptor tyrosine kinases. Expression of NRP1 in several cancers correlates with cancer stages and poor prognosis. Thus, NRP1 has been considered a therapeutic target and is the focus of multiple drug discovery initiatives. Vascular endothelial growth factor (VEGF) binds to the b1 domain of NRP1 through interactions between the C‐terminal arginine of VEGF and residues in the NRP1‐binding site including Tyr297, Tyr353, Asp320, Ser346 and Thr349. We obtained several complexes of the synthetic ligands and the NRP1‐b1 domain and used X‐ray crystallography and computational methods to analyse atomic details and hydration profile of this binding site. We observed side chain flexibility for Tyr297 and Asp320 in the six new high‐resolution crystal structures of arginine analogues bound to NRP1. In addition, we identified conserved water molecules in binding site regions which can be targeted for drug design. The computational prediction of the VEGF ligand‐binding site hydration map of NRP1 was in agreement with the experimentally derived, conserved hydration structure. Displacement of certain conserved water molecules by a ligand's functional groups may contribute to binding affinity, whilst other water molecules perform as protein–ligand bridges. Our report provides a comprehensive description of the binding site for the peptidic ligands’ C‐terminal arginines in the b1 domain of NRP1, highlights the importance of conserved structural waters in drug design and validates the utility of the computational hydration map prediction method in the context of neuropilin. DATABASE: The structures were deposited to the PDB with accession numbers PDB ID: 5IJR, 5IYY, 5JHK, 5J1X, 5JGQ, 5JGI. John Wiley and Sons Inc. 2018-02-25 2018-04 /pmc/articles/PMC5947257/ /pubmed/29430837 http://dx.doi.org/10.1111/febs.14405 Text en © 2018 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Mota, Filipa
Fotinou, Constantina
Rana, Rohini R.
Chan, A. W. Edith
Yelland, Tamas
Arooz, Mohamed T.
O'Leary, Andrew P.
Hutton, Jennie
Frankel, Paul
Zachary, Ian
Selwood, David
Djordjevic, Snezana
Architecture and hydration of the arginine‐binding site of neuropilin‐1
title Architecture and hydration of the arginine‐binding site of neuropilin‐1
title_full Architecture and hydration of the arginine‐binding site of neuropilin‐1
title_fullStr Architecture and hydration of the arginine‐binding site of neuropilin‐1
title_full_unstemmed Architecture and hydration of the arginine‐binding site of neuropilin‐1
title_short Architecture and hydration of the arginine‐binding site of neuropilin‐1
title_sort architecture and hydration of the arginine‐binding site of neuropilin‐1
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947257/
https://www.ncbi.nlm.nih.gov/pubmed/29430837
http://dx.doi.org/10.1111/febs.14405
work_keys_str_mv AT motafilipa architectureandhydrationoftheargininebindingsiteofneuropilin1
AT fotinouconstantina architectureandhydrationoftheargininebindingsiteofneuropilin1
AT ranarohinir architectureandhydrationoftheargininebindingsiteofneuropilin1
AT chanawedith architectureandhydrationoftheargininebindingsiteofneuropilin1
AT yellandtamas architectureandhydrationoftheargininebindingsiteofneuropilin1
AT aroozmohamedt architectureandhydrationoftheargininebindingsiteofneuropilin1
AT olearyandrewp architectureandhydrationoftheargininebindingsiteofneuropilin1
AT huttonjennie architectureandhydrationoftheargininebindingsiteofneuropilin1
AT frankelpaul architectureandhydrationoftheargininebindingsiteofneuropilin1
AT zacharyian architectureandhydrationoftheargininebindingsiteofneuropilin1
AT selwooddavid architectureandhydrationoftheargininebindingsiteofneuropilin1
AT djordjevicsnezana architectureandhydrationoftheargininebindingsiteofneuropilin1